We have obtained results for the 3rd group of volunteers in the 1st phase of clinical trials of the Amidine hydrochloride dosage form (DD217). Number of volunteers - 6 people. Administration - 60 mg once, orally. Preliminary results - serious adverse events haven’t been observed.